Search

Q4 results of Smith&Nephew, NuVASIVE

  • Spine bussiness is meeting solid milestones


  • Smith & Nephew, new leadership resulted in 7 % rise in stock


  • NuVasive expected to grow 4 - 6 % in 2020


Read more


source: Medtechdive





16 views

Recent Posts

See All

AbbotT, EUA, COVID-19 antigen test

Abbott gets EUA; COVID-19 antigen test #covid19test#antigen#covid19 Already in the antigen game - BD / Quidel / LumiraDx Abbott`s USP = scale + price scale - Abbott: 50 M / month by October - BD: 8 M

Contact
  • LinkedIn Social Icon

© 2020 IntMeDA